These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 11118429

  • 1. The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase.
    Deutsch DG, Glaser ST, Howell JM, Kunz JS, Puffenbarger RA, Hillard CJ, Abumrad N.
    J Biol Chem; 2001 Mar 09; 276(10):6967-73. PubMed ID: 11118429
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain.
    Glaser ST, Gatley SJ, Gifford AN.
    J Pharmacol Exp Ther; 2006 Mar 09; 316(3):1088-97. PubMed ID: 16278311
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.
    Glaser ST, Deutsch DG, Studholme KM, Zimov S, Yazulla S.
    Vis Neurosci; 2005 Mar 09; 22(6):693-705. PubMed ID: 16469181
    [Abstract] [Full Text] [Related]

  • 6. Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase.
    Kaczocha M, Hermann A, Glaser ST, Bojesen IN, Deutsch DG.
    J Biol Chem; 2006 Apr 07; 281(14):9066-75. PubMed ID: 16461355
    [Abstract] [Full Text] [Related]

  • 7. Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extra- but not intracellular pH.
    Holt S, Fowler CJ.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar 07; 367(3):237-44. PubMed ID: 12644895
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
    Dickason-Chesterfield AK, Kidd SR, Moore SA, Schaus JM, Liu B, Nomikos GG, Felder CC.
    Cell Mol Neurobiol; 2006 Mar 07; 26(4-6):407-23. PubMed ID: 16736384
    [Abstract] [Full Text] [Related]

  • 9. The 'specific' tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake.
    Thors L, Alajakku K, Fowler CJ.
    Br J Pharmacol; 2007 Apr 07; 150(7):951-60. PubMed ID: 17325653
    [Abstract] [Full Text] [Related]

  • 10. Involvement of fatty acid amide hydrolase and fatty acid binding protein 5 in the uptake of anandamide by cell lines with different levels of fatty acid amide hydrolase expression: a pharmacological study.
    Björklund E, Blomqvist A, Hedlin J, Persson E, Fowler CJ.
    PLoS One; 2014 Apr 07; 9(7):e103479. PubMed ID: 25078278
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Further evidence for the existence of a specific process for the membrane transport of anandamide.
    Ligresti A, Morera E, Van Der Stelt M, Monory K, Lutz B, Ortar G, Di Marzo V.
    Biochem J; 2004 May 15; 380(Pt 1):265-72. PubMed ID: 14969584
    [Abstract] [Full Text] [Related]

  • 14. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.
    Fowler CJ, Tiger G, Ligresti A, López-Rodríguez ML, Di Marzo V.
    Eur J Pharmacol; 2004 May 10; 492(1):1-11. PubMed ID: 15145699
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.
    Vandevoorde S, Fowler CJ.
    Br J Pharmacol; 2005 Aug 10; 145(7):885-93. PubMed ID: 15895107
    [Abstract] [Full Text] [Related]

  • 16. Correlating FAAH and anandamide cellular uptake inhibition using N-alkylcarbamate inhibitors: from ultrapotent to hyperpotent.
    Nicolussi S, Chicca A, Rau M, Rihs S, Soeberdt M, Abels C, Gertsch J.
    Biochem Pharmacol; 2014 Dec 15; 92(4):669-89. PubMed ID: 25283614
    [Abstract] [Full Text] [Related]

  • 17. A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors.
    Ueda N, Goparaju SK, Katayama K, Kurahashi Y, Suzuki H, Yamamoto S.
    J Med Invest; 1998 Aug 15; 45(1-4):27-36. PubMed ID: 9864962
    [Abstract] [Full Text] [Related]

  • 18. Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.
    Fegley D, Kathuria S, Mercier R, Li C, Goutopoulos A, Makriyannis A, Piomelli D.
    Proc Natl Acad Sci U S A; 2004 Jun 08; 101(23):8756-61. PubMed ID: 15138300
    [Abstract] [Full Text] [Related]

  • 19. Evidence against the presence of an anandamide transporter.
    Glaser ST, Abumrad NA, Fatade F, Kaczocha M, Studholme KM, Deutsch DG.
    Proc Natl Acad Sci U S A; 2003 Apr 01; 100(7):4269-74. PubMed ID: 12655057
    [Abstract] [Full Text] [Related]

  • 20. Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase.
    De Petrocellis L, Melck D, Ueda N, Maurelli S, Kurahashi Y, Yamamoto S, Marino G, Di Marzo V.
    Biochem Biophys Res Commun; 1997 Feb 03; 231(1):82-8. PubMed ID: 9070224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.